Pontifax

Prevail Therapeutics raises $50M for gene therapy in Parkinson’s, other neurodegenerative disorders

The company hopes the funding will move it toward the clinic. Active clinical programs of gene therapies in Parkinson's include efforts by Voyager Therapeutics and a university in Japan.

By Alaric DeArment

BioPharma, Startups

OrbiMed launches 89Bio with $60M Series A round to develop Teva’s NASH drug

The new company is headquartered in San Francisco, with R&D in Israel and has launched a Phase I study of BIO89-100, formerly TEV-47948.

By Alaric DeArment

With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?

Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.